These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 2674897

  • 21. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE.
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [Abstract] [Full Text] [Related]

  • 22. Relaxation by cromakalim and pinacidil of isolated smooth muscle cells from canine coronary artery-multiple sites of action.
    Rhim BY, Hong KW.
    Arch Int Pharmacodyn Ther; 1994 Dec; 328(1):67-81. PubMed ID: 7893192
    [Abstract] [Full Text] [Related]

  • 23. Cromakalim, pinacidil and RP 49356 activate a tolbutamide-sensitive K+ conductance in human skeletal muscle fibres.
    Quasthoff S, Spuler A, Lehmann-Horn F, Grafe P.
    Pflugers Arch; 1989 Dec; 414 Suppl 1():S179-80. PubMed ID: 2780252
    [No Abstract] [Full Text] [Related]

  • 24. Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries.
    Iwamoto T, Nishimura N, Morita T, Sukamoto T.
    J Pharm Pharmacol; 1993 Apr; 45(4):292-7. PubMed ID: 8098370
    [Abstract] [Full Text] [Related]

  • 25. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
    Yanagisawa T, Teshigawara T, Taira N.
    Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
    [Abstract] [Full Text] [Related]

  • 26. Modulation of rabbit aortic Ca(2+)-activated K+ channels by pinacidil, cromakalim, and glibenclamide.
    Gelband GH, McCullough JR.
    Am J Physiol; 1993 May; 264(5 Pt 1):C1119-27. PubMed ID: 8498475
    [Abstract] [Full Text] [Related]

  • 27. Dilating effect of perivascularly applied potassium channel openers cromakalim and pinacidil in rat and cat pial arteries in situ.
    Wahl M, Parsons AA, Schilling L.
    Cardiovasc Res; 1994 Dec; 28(12):1803-7. PubMed ID: 7867033
    [Abstract] [Full Text] [Related]

  • 28. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA, Stork AP.
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [Abstract] [Full Text] [Related]

  • 29. Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes.
    Escande D, Thuringer D, Le Guern S, Courteix J, Laville M, Cavero I.
    Pflugers Arch; 1989 Sep; 414(6):669-75. PubMed ID: 2510125
    [Abstract] [Full Text] [Related]

  • 30. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery.
    Ksoll E, Parsons AA, Mackert JR, Schilling L, Wahl M.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):377-83. PubMed ID: 1830131
    [Abstract] [Full Text] [Related]

  • 31. [Effect of potassium channel openers on hypoxic pulmonary vasoconstriction].
    Matsumoto H, Nakano H, Akiba Y, Osanai S, Tobise K, Onodera S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1488-95. PubMed ID: 1434222
    [Abstract] [Full Text] [Related]

  • 32. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K, Barras M, Zazzi-Sudriez E, Martin DJ, Armstrong JM, Hicks PE.
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [Abstract] [Full Text] [Related]

  • 33. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I, Minshall E, Downing SJ, Hollingsworth M, Sadraei H.
    Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
    [Abstract] [Full Text] [Related]

  • 34. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
    Satoh H.
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):863-8. PubMed ID: 7509906
    [Abstract] [Full Text] [Related]

  • 35. Effects of pinacidil, cromakalim, and nicorandil on potassium currents of rat basilar artery smooth muscle.
    Zhang H, Stockbridge N, Weir B.
    Adv Exp Med Biol; 1991 Dec; 304():531-41. PubMed ID: 1839488
    [No Abstract] [Full Text] [Related]

  • 36. Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return.
    Gotanda K, Yokoyama H, Satoh K, Taira N.
    Cardiovasc Drugs Ther; 1989 Aug; 3(4):507-15. PubMed ID: 2488102
    [Abstract] [Full Text] [Related]

  • 37. Differential effects of pinacidil and cromakalim on vascular relaxation and sympathetic neurotransmission.
    Cai B, Hao Q, Greenberg SS, deBoisblanc B, Gillott D, Goharderakhshan R, Summer WR, Hyman A, Lippton H.
    Can J Physiol Pharmacol; 1994 Jul; 72(7):801-10. PubMed ID: 7828089
    [Abstract] [Full Text] [Related]

  • 38. Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta.
    Kashiwabara T, Nakajima S, Izawa T, Fukushima H, Nishikori K.
    Eur J Pharmacol; 1991 Apr 10; 196(1):1-7. PubMed ID: 1678711
    [Abstract] [Full Text] [Related]

  • 39. Effects of potassium channel openers in isolated human cerebral arteries.
    Hempelmann RG, Barth HL, Mehdorn HM, Pradel RH, Ziegler A.
    Neurosurgery; 1995 Dec 10; 37(6):1146-53. PubMed ID: 8584155
    [Abstract] [Full Text] [Related]

  • 40. Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.
    Nagai H, Kitagaki K, Goto S, Suda H, Koda A.
    Jpn J Pharmacol; 1991 May 10; 56(1):13-21. PubMed ID: 1831870
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.